RCL | 2.30% | 348.51 | +2.74% | 768 | |
EMR | 2.27% | 144.39 | +2.92% | 1,794 | |
KD | 2.24% | 39.16 | +0.77% | 5,760 | |
ARMK | 2.24% | 43.27 | +0.25% | 5,676 | |
SCHW | 2.23% | 93.10 | +2.02% | 2,658 | |
ADSK | 2.22% | 292.16 | +0.93% | 780 | |
FLTRF | 2.21% | 22,430.0 | +2.75% | 852 | |
CTRE | 2.20% | 30.29 | -0.39% | 7,806 | |
SRAD | 2.17% | 30.36 | +1.37% | 8,520 | |
MTZ | 2.16% | 176.57 | +1.27% | 1,392 |
Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF is an exchange traded fund launched and managed by Innovator Capital Management, LLC. It is co-managed by Penserra Capital Management, LLC. The fund invests in public equity markets of the United States. It invests in stocks of companies operating across diversified sectors. It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track the performance of the IBD Breakout Stocks Index, by using full replication technique. Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF was formed on September 13, 2018 and is domiciled in the United States.